Bruker Corporation and JMI Laboratories Announce a Collaboration for Mass Spectrometry-based Microbial Identification of Fungi

Published: Jun 18, 2012

SAN FRANCISCO--(BUSINESS WIRE)--At the 112th General Meeting of the American Society of Microbiology (ASM) in San Francisco, Bruker announces a new collaboration with JMI Laboratories in the field of fungal identification by proteomics fingerprinting. JMI Laboratories is applying the Bruker MALDI Biotyperâ„¢ to a wide variety of international antimicrobial resistance surveillance studies utilizing the SENTRY Program platform (>300 sites in more than 40 countries and six continents). Among these programs, comprehensive sampling of invasive fungal infections involves nearly 2,000 samples of yeast and moulds, each requiring the highest quality of identifications, and currently requiring gene amplification and sequencing. The Bruker MALDI Biotyper will streamline reference-quality identifications via its rapidly evolving library of clinically important fungi.

Back to news